Journal of Clinical Oncology

Vol. 44, Issue 16_suppl Issue 16_suppl 2026
7213
Articles

Articles in this Issue

Does the FIGO 2018 cervical cancer staging system need revision? Insights from a global survey.

Vishal Toka, Yasar Syed, Raghunadharao Digumarti et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e17513

e17513 Background: FIGO 2018 incorporated imaging and nodal status into cervical cancer staging; however, concerns remain...

Uncoupling of MT1E transcription and translation in high-CNA colorectal cancer: A proteostatic adaptation as driver of aggressiveness.

Wen-Ying Lin, Hao-Wei Teng Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e15577

e15577 Background: Somatic copy number alterations (CNAs) drive chromosomal instability in colorectal cancer (CRC). We aim...

Survival outcomes in individuals with cancer and pre-existing autoimmune disease receiving immune checkpoint inhibitors: A multicenter, propensity-matched real-world survival analysis.

Nehemias Guevara, Wint Yan Aung, Syeda Ashna Fatima Kamal et al. Jun 01, 2026 pp. 11098-11098 10.1200/jco.2026.44.16_suppl.11098

11098 Background: Autoimmune disease (AID) affects approximately 5–10% of individuals with cancer. Although immune checkpo...

Characterization of ENTPD1/CD39-mediated myeloid-T-cell crosstalk and its role in immunotherapy response in triple-negative breast cancer.

Xiaojian Ni, Zi Han Hu Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e14564

e14564 Background: Immunotherapy efficacy in triple-negative breast cancer (TNBC) is limited by mechanisms of immune suppr...

Corruption as an upstream determinant of global cancer outcomes.

Tara Pattilachan Menon, Taral Kumar Jella, Nishwant Swami et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e23031

e23031 Background: Corruption undermines health systems globally through resource diversion and weakened governance, yet i...

Long-term incidence of hypothyroidism and thyroiditis after CAR T-cell therapy versus standard chemotherapy in hematologic malignancies: A propensity-matched multi-institutional cohort study.

Taha Hassan, Mohamed Jimale, Zuhair Zaidi et al. Jun 01, 2026 pp. 11148-11148 10.1200/jco.2026.44.16_suppl.11148

11148 Background: Thyroid dysfunction is a common endocrine immune-related adverse event with modern cancer immunotherapie...

Patient experience with later line chemotherapy in four tumor types.

Patricia Dorling, Alexandra Kissling, Emily Mulvihill et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e24142

e24142 Background: Understanding patient experiences with prior therapies offers crucial context for assessing the quality...

Digital twin models for counterfactual prediction in NSCLC: A validation study using clinical trial data.

Aaron B. Cohen, Sandra Griffith, Melissa Estevez et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e20517

e20517 Background: Digital twin models (DTMs) developed on real world data can estimate a patient’s response to treatments...

COVID-19 mRNA vaccination and risk of immune-related adverse events in ICI-treated cancer patients.

Andrea Yun-En Sun, Po-Huang Chen, Cho-Hao Howard Lee Jun 01, 2026 pp. 2641-2641 10.1200/jco.2026.44.16_suppl.2641

2641 Background: Immune checkpoint inhibitors (ICIs) are now standard-of-care in cancer therapy; however, concerns persist...

Use of surrogate endpoints in health technology assessment: A review of company submissions for cancer drugs in Singapore.

Jiamin Ong, Lydia Loke, Liang Lin Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e23147

e23147 Background: Surrogate endpoints are increasingly used to accelerate clinical trials and regulatory approval of new...

COMFORT Survey: A comparison of the comfort level of hematologic and solid tumor oncology specialists with serious illness conversations.

Michael J. Tang, Kayley Ancy, Allison De La Rosa et al. Jun 01, 2026 pp. 12102-12102 10.1200/jco.2026.44.16_suppl.12102

12102 Background: Serious illness conversations (SICs) are essential in aligning medical care with the values and goals of...

Beyond didactics: Simulation-based education in hematology/oncology training—A scoping review.

Sharouk Khanjar, Zhu Chin Ng Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e21010

e21010 Background: Clinical oncology exposure in residency is often varied and limited, contributing to difficulty in tran...

Neoadjuvant therapy vs. standard of care in oral cavity squamous cell carcinoma: A meta-analysis.

Alexandra Feathers, Ashish Samaddar, Hannah Sturm et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e18069

e18069 Background: Historically, locally advanced, resectable oral squamous cell carcinoma was treated with upfront surger...

EGFR tyrosine kinase inhibitor plus angiogenesis inhibitor combination therapy in treatment-naïve <i>EGFR</i> -mutant advanced non–small cell lung cancer: A systematic review and meta-analysis.

Gaurav Kansal, Shankar Biswas, Yashasvi Srivastava et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e20754

e20754 Background: The benefit of adding angiogenesis inhibitors to EGFR-TKIs in treatment naive EGFR mutant NSCLC remains...

Frailty among hospitalized patients with pancreatic cancer: A National Inpatient analysis.

Srijani Thannir, Michelle Koifman, Mrunanjali Gaddam et al. Jun 01, 2026 pp. 11183-11183 10.1200/jco.2026.44.16_suppl.11183

11183 Background: Frailty is increasingly recognized as a key determinant of outcomes in older adults with cancer; however...

Genetic and epigenetic modulation of CAR T-cell responses: A systematic review exploring the influence of host genetic variations and epigenetic modifications on CAR T-cell therapy outcomes.

Ashvath Arumugam Pillai, Sai K. Reddy Pasya, Nikita Tompe et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e15197

e15197 Background: Chimeric antigen receptor (CAR) T-cell therapy demonstrates variable efficacy in hematological malignan...

Mortality trends and demographic disparities in breast cancer deaths with co-existing diabetes mellitus among U.S. adults ≥45 years, 1999–2020.

Bisma Tariq, Suleman Saeed, Hamid Bin Tariq et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e13135

e13135 Background: Breast cancer stands out as a considerable cause of mortality attributed to cancer, and diabetes mellit...

SMS message sentiment as a predictive indicator of quality of life and program adherence in oncology nutrition.

Mélanie Guirette, Vera Steullet, Ethan Basch et al. Jun 01, 2026 pp. 1627-1627 10.1200/jco.2026.44.16_suppl.1627

1627 Background: A text-message based artificial intelligence nutrition platform called “Ina” was previously developed and...

Clinicopathologic characteristics and cancer-specific survival in adolescents and young adults with endometrial cancer: A population-based SEER analysis.

Priyanka Nagdev, nishita shetty, Heena Arshad Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e17615

e17615 Background: Endometrial cancer is the most common gynecologic malignancy in the United States, with an increasing i...

Treatment patterns and outcomes in invasive lobular versus ductal breast carcinoma: A real-world analysis.

Manuela Estrada, Maria Paula Uchima-Vera, Maria Alejandra Gomez-Gutierrez et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e12665

e12665 Background: Invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) differ in tumor biology; however,...

Residual cancer burden after neoadjuvant therapy in lung cancer: A single-institution cohort.

Leena Alhusari, Samhitha Gundakaram, Madho Mal et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e20050

e20050 Background: Residual cancer burden (RCB) after neoadjuvant therapy may predict recurrence and survival, but real-wo...

The gap: Recognizing the inequities in oncology research and clinical practice guidelines—An analysis of clinical guidelines in multiple myeloma.

Samuel Ranger, Maya Nicole Birhiray, Ruemu Ejedafeta Birhiray et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e23213

e23213 Background: Despite significant efforts to address inequities in oncology research, and American Society of Clinica...

Sentinel lymph node positivity in microinvasive breast cancer: A systematic review and meta-analysis.

Hunter Wayne Brady, Jasneet Gill, Christiana Coonradt et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e12620

e12620 Background: Breast cancer is a leading cause of cancer-related mortality. Advances in screening and imaging have in...

Toripalimab plus chemotherapy and radiotherapy for treatment-naïve advanced esophageal squamous cell carcinoma: Long-term survival and recurrence patterns.

Lei Wu, Gang Wan, Yixiang Zhu et al. Jun 01, 2026 pp. 4064-4064 10.1200/jco.2026.44.16_suppl.4064

4064 Background: Concurrent chemoradiotherapy plus PD-1 blockade is standard for locally advanced esophageal squamous cell...

Barriers to fertility preservation counseling in young cancer patients: A retrospective chart review.

Ivana Lopez-Nieves, Lois Schwarz, Brooke Worster Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e13732

e13732 Background: The possibility of infertility is a major concern for young cancer patients facing chemotherapy. While...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0732-183X
E-ISSN 1527-7755
Subject Health Sciences
Language English
View Full Journal Page